Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
An agentic AI system enhances clinical detection of immunotherapy toxicities: a multi-phase validation study.
Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026
Acquired Hemophilia A After Neoadjuvant Immunotherapy for Renal Cell Carcinoma.
Journal: Rhode Island medical journal (2013)
Published: January 27, 2026
Clinical Characteristics and Outcomes of Immune Checkpoint Inhibitor Associated Renal Toxicities: A Retrospective Pan-Cancer Cohort Study.
Journal: Clinical therapeutics
Published: December 24, 2025
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer.
Journal: Cancer treatment reviews
Published: October 29, 2025
Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and Considerations.
Journal: Current oncology reports
Published: October 28, 2025
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal: Cancer research communications
Published: October 21, 2025
Immune-related adverse effects in palliative care clinic.
Journal: Annals of palliative medicine
Published: September 25, 2025
Corrigendum to "Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)" [Best Pract Res Clin Haematol 38 2 2025].
Journal: Best practice & research. Clinical haematology
Published: September 07, 2025
Genomic drivers of brain metastases in lung cancer.
Journal: Neuro-oncology advances
Published: September 03, 2025
Immunotherapy-Related Adverse Events: A Primer for the Non-Oncologist.
Journal: Rhode Island medical journal (2013)
Published: May 28, 2025
Merkel Cell Carcinoma: Current Treatment Landscape and Emerging Therapeutic Targets.
Journal: Current oncology reports
Published: May 22, 2025
The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancer.
Journal: NPJ precision oncology
Published: May 19, 2025
Last Updated: 09/26/2026